Michael J. Fox Foundation PD Therapeutics ... ( The Michael J. Fox Foundation for Pa...)

Michael J. Fox Foundation PD Therapeutics Conference

Date:8/7/2008

The Michael J. Fox Foundation for Parkinson's Research (MJFF) will host its second annual PD Therapeutics Conference on Monday, September 15, in Chicago.

Chaired by Jeffrey Kordower, PhD, Director, Research Center for Brain Repair and Jean-Schweppe Armour Professor of Neurological Sciences at Rush University Medical Center, the conference will bring together academic and industry scientists to focus on novel research advances impacting development of improved disease-modifying and symptomatic interventions for the diagnosis and treatment of PD.

Select MJFF-funded investigators will present research on topics including novel neuroprotective agents, innovative mechanisms to address disease symptoms and improvements in relevant animal models, and biomarker discovery/development.

In addition to scientific talks, a small poster session will highlight novel targets and animal models relevant to PD research.

Confirmed speakers include:

D. James Surmeier, PhD (Northwestern University), on the FDA-approved diabetes drug that may protect dopamine neurons in the Parkinson's brain

Anders Bjrkund, MD, PhD (Lund University, Sweden), on the role of serotonin (better known for the part it plays in depression) in dyskinesias, the disruptive movements brought on by long-term dopamine replacement therapy

Erwan Bezard, PhD (Universite Victor Segalen, Bordeaux, France), and Piu Chan, MD, PhD (Beijing Institute of Geriatrics, China), on conducting pre-clinical and clinical research in China

Patrik Brundin, MD, PhD (Lund University, Sweden), on the state of cell replacement approaches for Parkinson's disease

Registration is free for accredited members of the press.

Last year's inaugural conference in New York City drew a multidisciplinary audience of nearly 200 academic, pharmaceutical and biotechnology industry researchers.

'/>"/>

Contact: Holly Barkhymer
hbarkhymer@michaeljfox.org
212-509-0995 x242
The Michael J. Fox Foundation for Parkinson's Research
Source:Eurekalert

0

GOOD

Post Your Comments:

(Date:5/18/2012)... quantities are very small, but in milk powder and ... livestock were found. Researchers from the University of Almera ... quickly and precisely. , Antibiotics, such as tilmicosine, or ... in order to avoid illness, but they can remain ... (UAL) have confirmed this, whilst checking new methodology to ...

(Date:5/17/2012)... of a Smart car, with a shell large enough to ... University have found just such a specimen the fossilized ... what is now Colombia. , The turtle in question is ... part of a group of side-necked turtles known as pelomedusoides. ... discovered in 2005 in a coal mine that was part ...

(Date:5/17/2012)... London have shown that zebrafish could be used ... , The study, published online in the journal ... modify their behaviour in response to varying situations. ... of Biological and Chemical Sciences who led the ... most useful animal models for studying the developmental ...

[0] A new method detects traces of veterinary drugs in baby food [0] Ancient giant turtle fossil revealed [0] Zebrafish could hold the key to understanding psychiatric disorders

... (magnetic resonance imaging) body scanner in the world will be ... th February). , The Achieva 3T MR Scanner has been ... by researchers to further their studies in a wide range ... will revolutionise the way scanning takes place and means that ...

... looking to nature -- specifically, to ants, bees and ... disaster relief efforts. , At the center of the ... -- specifically, civil engineers, who historically have had a ... physical infrastructures. , Supported by a five-year $2.37 million ...

... GARBAN project, drawn up by Navarre University, will enable ... hepatitis. , The School of Engineering at Navarre University ... Gipuzkoa (CEIT) have launched an advanced biochemical analysis tool ... accelerate their diagnosis and identify new therapeutic targets (lines ...

Other Biology News:Next Generation Body Scanner Launched By The University Of Manchester 2 Next Generation Body Scanner Launched By The University Of Manchester 3 Insects, viruses could hold key for better human teamwork in disasters 2 Insects, viruses could hold key for better human teamwork in disasters 3 Insects, viruses could hold key for better human teamwork in disasters 4 Analysis Of Human Genome To Predict The Development Of Illnesses 2

Next Generation Body Scanner Launched By The University Of Manchester Insects, viruses could hold key for better human teamwork in disasters Analysis Of Human Genome To Predict The Development Of Illnesses

(Date:5/15/2012)... DIEGO, May 15, 2012 Cardium Therapeutics ... its financial results for the first quarter ended ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ... 2012 financial results, Cardium reported its goals for ... and include (1) plans to advance commercialization of ...

(Date:5/15/2012)... Connecticut and SHENZHEN, China, May 15, 2012 ... organizations, announced today that a new Roche GS FLX+ ... Shenzhen, China. The goal is to complement the existing ... long read sequencing capability. The GS FLX+ ... features the unique combination of long reads, exceptional accuracy ...

(Date:5/14/2012)... LED light with 20 times the efficiency of an ... and store data 100 times faster than those we ... if we could turn waste heat into electricity, or ... more efficient, and more accessible? , The (IEE) ... world-ranked collaborative research campus that boasts five Nobel laureates ...

(Date:5/14/2012)... May 14, 2012 More than one billion people worldwide ... decrease in the ability of the lens in the eye ... all seen others struggle with trying to read menus and ... To combat this change in vision, which often begins around ... the choices for lenses that are both multifocal ...

[0] Cardium Presents First Quarter 2012 Financial Results and Recent Developments [0] BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research [0] Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara [0] New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life

... Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) today reported the results ... 31, 2008. All dollar amounts referenced,herein are in Canadian ... our cash and cash equivalents totaled $12.4 million,compared with ... loss for the second quarter of 2008 was $7.4 ...

... to Evaluate Treatment of Coronary Artery Disease ... Patients in Real-World Setting, ABBOTT ... XIENCE V(TM) USA post-approval study, with six,hospital centers already recruiting and ... approved the XIENCE V(TM),Everolimus Eluting Coronary Stent System. The XIENCE V ...

... Bio-Pharma Solutions, Inc.,(ABS), a global provider of ... is pleased to announce that Nandini,Hadker, an ... been promoted to,Executive Director and will oversee ... has been appointed,President & CEO of the ...

Vasogen Announces Second Quarter 2008 Results Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent Abt Bio-Pharma Solutions, Inc. Names Nandini Hadker as Executive Director, Succeeding Susan Windham-Bannister

mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...

Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...

Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....

NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...

Biology Products:

Rabbit Anti-mu Opioid Receptor splice variant Antibody, Unconjugated from ABR-Affinity BioReagents Rabbit Anti-Human BAR Antibody, Unconjugated from CHEMICON Sheep Anti-EBNA 3B Polyclonal Antibody, Unconjugated from Abcam Mouse Anti-Human NANS Monoclonal Antibody, Unconjugated, Clone 3G6 from ABR-Affinity BioReagents

Michael J. Fox Foundation PD Therapeutics ...( The Michael J. Fox Foundation for Pa...)